Dizziness, particularly vertigo, is a common symptom encountered in clinical practice. Despite its prevalence, it often poses diagnostic challenges for healthcare professionals. This article aims to provide a comprehensive guide to understanding and managing vertigo.
Vertigo is a subtype of dizziness characterized by a sensation of spinning or moving when one is stationary. It is often associated with disorders affecting the inner ear or brain. The key to differentiating vertigo from other forms of dizziness lies in detailed history taking and careful physical examination.
A thorough assessment of a patient with vertigo should include a complete history of the presenting symptoms, focusing on the onset, duration, frequency, and associated symptoms. Physical examination should assess the vestibular, auditory, and neurological systems. Special tests like the Dix-Hallpike maneuver and head impulse test can help diagnose benign paroxysmal positional vertigo and vestibular neuritis respectively.
Vertigo can be peripheral or central in origin. Peripheral vertigo, the most common type, is usually associated with benign conditions like benign paroxysmal positional vertigo, Meniere's disease, and vestibular neuritis. Central vertigo, though less common, may indicate serious conditions like stroke or multiple sclerosis. Distinguishing between these two types requires careful interpretation of the patient's history, examination findings, and sometimes, further investigations.
Management of vertigo should be tailored to the underlying cause. Peripheral vertigo can often be managed with vestibular rehabilitation exercises and medications like meclizine and scopolamine. Central vertigo requires prompt identification and management of the underlying condition. Patient education and reassurance also play a crucial role in managing this distressing symptom.
In conclusion, vertigo is a complex symptom that requires a systematic approach for accurate diagnosis and management. By understanding its pathophysiology and applying comprehensive clinical assessment skills, healthcare professionals can effectively manage this common symptom and significantly improve patient outcomes.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation